AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Sabra Health Care REIT, Inc.

$20.52 +$1.37 (+7.15%)
NASDAQ · 11 Sep 2026 20:00 UTC
Previous Close
$20.83
Day Range
$20.5$21.06
Year Range
$17.17$22.77
Market Cap
5.17B
AVG Volume
2.82M
Trailing/Forward PE
77.73/26.8
PEG ratio
1.24
Dividend Yield
5.85%
Next Earnings Date
2026-11-04
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
0250M500M750M1B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SBRA Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
26 Q2859.56M
26 Q1812.84M
25 Q4774.63M
25 Q3745.08M
25 Q2733.04M
25 Q1720.03M
24 Q4703.24M
24 Q3684.29M
24 Q2667.27M
24 Q1651.64M
Net Income (USD) · TTM
050M100M150M200M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SBRA Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
26 Q265.44M
26 Q1156.19M
25 Q4155.61M
25 Q3175.08M
25 Q2182.33M
25 Q1140.76M
24 Q4126.71M
24 Q397.17M
24 Q252.28M
24 Q149.5M
Operating Income (USD) · TTM
0100M200M300M400M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SBRA Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
26 Q2101.78M
26 Q1235.56M
25 Q4263.47M
25 Q3266.18M
25 Q2271M
25 Q1266.02M
24 Q4256.58M
24 Q3243.61M
24 Q2280.31M
24 Q1315.16M
EBITDA (USD) · TTM
0200M400M600M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SBRA EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
26 Q2358.9M
26 Q1466.49M
25 Q4456.83M
25 Q3474.04M
25 Q2475.39M
25 Q1433.62M
24 Q4420.34M
24 Q3383.61M
24 Q2382.97M
24 Q1389.38M
Cash Flows (USD) · TTM
0100M200M300M400M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SBRA Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
26 Q2346.41M
26 Q1366.71M
25 Q4348.61M
25 Q3341.15M
25 Q2338.84M
25 Q1338.01M
24 Q4310.54M
24 Q3309.31M
24 Q2214.25M
24 Q1204.45M
EPS (USD) · TTM
00.20.40.60.824 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SBRA EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
26 Q20.26
26 Q10.63
25 Q40.64
25 Q30.72
25 Q20.76
25 Q10.59
24 Q40.53
24 Q30.41
24 Q20.22
24 Q10.21
Expenses (USD) · TTM
050M100M150MSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SBRA Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
26 Q285.31M
26 Q155.84M
25 Q453.71M
25 Q350.83M
25 Q250.68M
25 Q150.91M
24 Q450.07M
24 Q353.71M
24 Q2132.7M
24 Q1129.49M
Shares Outstanding (USD) · TTM
-20M-10M010MBuybacks (Repurchases)Stock-Based Compensation24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SBRA Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
26 Q2-13.13M
26 Q1-3.5M
25 Q4-5.97M
25 Q3-5.44M
25 Q2-5.15M
25 Q1-6.39M
24 Q4-8.99M
24 Q3-8.41M
24 Q2-8.02M
24 Q1-4.77M
Dividends (USD)
00.511.5May 24Aug 24Nov 24Feb 25May 25Aug 25Nov 25Feb 26May 26Aug 26
SBRA Dividends (USD) by quarter
PeriodDividends (USD)
Aug 260.3
May 260.3
Feb 260.3
Nov 250.3
Aug 250.3
May 250.3
Feb 250.3
Nov 240.3
Aug 240.3
May 240.3
Employee Count
0204060802016201720182019202020212022202320242025
SBRA Employee Count by quarter
PeriodEmployee Count
202558
202450
202348
202242
202142
202038
201934
201831
201761
201614
PE Ratio
20406080100med 31.75Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
SBRA PE Ratio by quarter
PeriodPE Ratio
Sep 2679.1
Sep 2680.1
Aug 2679.45
Aug 2678.6
Aug 2678.33
Aug 2681.11
Jul 2634.18
Jul 2636.1
Jul 2632.46
Jul 2631.67
Jul 2632.55
Jun 2631.54
Jun 2629.25
Jun 2630.24
Jun 2629.8
May 2632.11
May 2633.45
May 2633.37
May 2633.5
May 2632.87
Apr 2632.2
Apr 2633.14
Apr 2632.79
Apr 2631.83
Mar 2631.43
Mar 2631.39
Mar 2633.05
Mar 2632.72
Feb 2632.93
Feb 2631.94
Feb 2632.32
Feb 2626.08
Jan 2625.66
Jan 2625.79
Jan 2626.36
Jan 2626.42
Jan 2626.24
Dec 2525.75
Dec 2525.61
Dec 2526.28
Dec 2526.42
Nov 2526.73
Nov 2525.66
Nov 2525.55
Nov 2525.87
Oct 2523.26
Oct 2523.6
Oct 2523.66
Oct 2523.15
Oct 2523.68
Sep 2524.58
Sep 2524.42
Sep 2524.86
Sep 2524.84
Aug 2524.94
Aug 2525.52
Aug 2524.09
Aug 2524.43
Aug 2530.91
Jul 2530.79
Jul 2530.54
Jul 2531.2
Jul 2531.45
Jun 2530.86
Jun 2530.84
Jun 2530.78
Jun 2530.17
May 2529.54
May 2529.47
May 2530.2
May 2530.74
May 2532.53
Apr 2532.53
Apr 2533.87
Apr 2532.4
Apr 2532.27
Mar 2532.75
Mar 2532.23
Mar 2532.3
Mar 2531.48
Feb 2531.01
Feb 2529.67
Feb 2539.83
Feb 2540.24
Jan 2540.29
Jan 2540.8
Jan 2540.84
Jan 2540
Jan 2541.61
Dec 2441.04
Dec 2440.89
Dec 2442.19
Dec 2443.5
Nov 2445.16
Nov 2444.39
Nov 2443.83
Nov 2447.14
Nov 2444.94
Oct 2483.28
Oct 2482.75
Free Cash Flow Yield
4%5%6%7%8%9%med 7.53%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
SBRA Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 266.69%
Sep 266.61%
Aug 266.66%
Aug 266.73%
Aug 266.76%
Aug 266.53%
Jul 266.87%
Jul 266.5%
Jul 267.23%
Jul 267.41%
Jul 267.21%
Jun 267.44%
Jun 268.03%
Jun 267.77%
Jun 267.88%
May 267.31%
May 267.02%
May 267.04%
May 267.01%
May 267.14%
Apr 266.96%
Apr 266.76%
Apr 266.83%
Apr 267.04%
Mar 267.13%
Mar 267.14%
Mar 266.78%
Mar 266.85%
Feb 266.8%
Feb 267.01%
Feb 266.93%
Feb 267.47%
Jan 267.59%
Jan 267.56%
Jan 267.39%
Jan 267.38%
Jan 267.43%
Dec 257.57%
Dec 257.61%
Dec 257.41%
Dec 257.38%
Nov 257.29%
Nov 257.59%
Nov 257.63%
Nov 257.53%
Oct 257.99%
Oct 257.88%
Oct 257.85%
Oct 258.03%
Oct 257.85%
Sep 257.56%
Sep 257.61%
Sep 257.47%
Sep 257.48%
Aug 257.45%
Aug 257.28%
Aug 257.71%
Aug 257.61%
Aug 257.77%
Jul 257.8%
Jul 257.86%
Jul 257.7%
Jul 257.63%
Jun 257.78%
Jun 257.79%
Jun 257.8%
Jun 257.96%
May 258.13%
May 258.15%
May 257.95%
May 257.81%
May 257.53%
Apr 257.53%
Apr 257.24%
Apr 257.56%
Apr 257.6%
Mar 257.48%
Mar 257.6%
Mar 257.59%
Mar 257.78%
Feb 257.9%
Feb 258.26%
Feb 257.99%
Feb 257.91%
Jan 257.9%
Jan 257.8%
Jan 257.79%
Jan 257.96%
Jan 257.65%
Dec 247.76%
Dec 247.78%
Dec 247.54%
Dec 247.32%
Nov 247.05%
Nov 247.17%
Nov 247.26%
Nov 246.75%
Nov 247.08%
Oct 244.92%
Oct 244.95%
Price to Sales
55.566.57med 6.06Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
SBRA Price to Sales by quarter
PeriodPrice to Sales
Sep 266.02
Sep 266.1
Aug 266.05
Aug 265.98
Aug 265.96
Aug 266.17
Jul 266.57
Jul 266.94
Jul 266.24
Jul 266.09
Jul 266.25
Jun 266.06
Jun 265.62
Jun 265.81
Jun 265.73
May 266.17
May 266.43
May 266.41
May 266.44
May 266.32
Apr 266.47
Apr 266.66
Apr 266.59
Apr 266.39
Mar 266.31
Mar 266.31
Mar 266.64
Mar 266.57
Feb 266.62
Feb 266.42
Feb 266.49
Feb 266.13
Jan 266.03
Jan 266.06
Jan 266.19
Jan 266.21
Jan 266.17
Dec 256.05
Dec 256.02
Dec 256.18
Dec 256.21
Nov 256.28
Nov 256.03
Nov 256
Nov 256.08
Oct 255.79
Oct 255.87
Oct 255.89
Oct 255.76
Oct 255.89
Sep 256.11
Sep 256.07
Sep 256.18
Sep 256.18
Aug 256.2
Aug 256.35
Aug 255.99
Aug 256.08
Aug 256.04
Jul 256.02
Jul 255.97
Jul 256.1
Jul 256.15
Jun 256.03
Jun 256.03
Jun 256.02
Jun 255.9
May 255.78
May 255.76
May 255.9
May 256.01
May 255.86
Apr 255.86
Apr 256.1
Apr 255.84
Apr 255.81
Mar 255.9
Mar 255.81
Mar 255.82
Mar 255.67
Feb 255.59
Feb 255.35
Feb 255.66
Feb 255.71
Jan 255.72
Jan 255.79
Jan 255.8
Jan 255.68
Jan 255.91
Dec 245.83
Dec 245.81
Dec 245.99
Dec 246.18
Nov 246.41
Nov 246.3
Nov 246.22
Nov 246.69
Nov 246.38
Oct 246.53
Oct 246.48
EV/EBITDA
121416182022med 15.6Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
SBRA EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 2621.15
Sep 2621.33
Aug 2621.21
Aug 2621.06
Aug 2621.01
Aug 2621.51
Jul 2616.95
Jul 2617.59
Jul 2616.38
Jul 2616.11
Jul 2616.4
Jun 2616.07
Jun 2615.3
Jun 2615.63
Jun 2615.49
May 2616.26
May 2616.71
May 2616.68
May 2616.72
May 2616.51
Apr 2616.39
Apr 2616.71
Apr 2616.59
Apr 2616.27
Mar 2616.13
Mar 2616.12
Mar 2616.68
Mar 2616.57
Feb 2616.64
Feb 2616.31
Feb 2616.44
Feb 2614.72
Jan 2614.57
Jan 2614.61
Jan 2614.83
Jan 2614.85
Jan 2614.78
Dec 2514.6
Dec 2514.55
Dec 2514.8
Dec 2514.85
Nov 2514.96
Nov 2514.57
Nov 2514.53
Nov 2514.65
Oct 2514.01
Oct 2514.14
Oct 2514.16
Oct 2513.97
Oct 2514.17
Sep 2514.51
Sep 2514.45
Sep 2514.62
Sep 2514.61
Aug 2514.65
Aug 2514.87
Aug 2514.33
Aug 2514.46
Aug 2515.56
Jul 2515.53
Jul 2515.44
Jul 2515.66
Jul 2515.74
Jun 2515.55
Jun 2515.54
Jun 2515.52
Jun 2515.32
May 2515.12
May 2515.1
May 2515.33
May 2515.51
May 2515.48
Apr 2515.48
Apr 2515.88
Apr 2515.44
Apr 2515.4
Mar 2515.54
Mar 2515.39
Mar 2515.41
Mar 2515.16
Feb 2515.02
Feb 2514.62
Feb 2516.39
Feb 2516.49
Jan 2516.5
Jan 2516.63
Jan 2516.64
Jan 2516.43
Jan 2516.84
Dec 2416.69
Dec 2416.66
Dec 2416.99
Dec 2417.32
Nov 2417.74
Nov 2417.54
Nov 2417.4
Nov 2418.24
Nov 2417.68
Oct 2417.74
Oct 2417.67
Price/Operating Cashflow
1213141516med 13.27Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
SBRA Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 2613.93
Sep 2614.11
Aug 2613.99
Aug 2613.84
Aug 2613.8
Aug 2614.28
Jul 2614.56
Jul 2615.37
Jul 2613.83
Jul 2613.49
Jul 2613.86
Jun 2613.43
Jun 2612.46
Jun 2612.88
Jun 2612.69
May 2613.68
May 2614.25
May 2614.21
May 2614.27
May 2614
Apr 2614.37
Apr 2614.79
Apr 2614.64
Apr 2614.21
Mar 2614.03
Mar 2614.01
Mar 2614.75
Mar 2614.61
Feb 2614.7
Feb 2614.26
Feb 2614.43
Feb 2613.38
Jan 2613.17
Jan 2613.23
Jan 2613.53
Jan 2613.56
Jan 2613.47
Dec 2513.21
Dec 2513.14
Dec 2513.49
Dec 2513.56
Nov 2513.72
Nov 2513.17
Nov 2513.11
Nov 2513.28
Oct 2512.52
Oct 2512.7
Oct 2512.73
Oct 2512.46
Oct 2512.74
Sep 2513.22
Sep 2513.14
Sep 2513.38
Sep 2513.37
Aug 2513.42
Aug 2513.73
Aug 2512.96
Aug 2513.15
Aug 2512.87
Jul 2512.82
Jul 2512.72
Jul 2512.99
Jul 2513.1
Jun 2512.85
Jun 2512.84
Jun 2512.82
Jun 2512.56
May 2512.3
May 2512.27
May 2512.58
May 2512.8
May 2513.27
Apr 2513.27
Apr 2513.82
Apr 2513.22
Apr 2513.17
Mar 2513.36
Mar 2513.15
Mar 2513.18
Mar 2512.85
Feb 2512.65
Feb 2512.11
Feb 2512.51
Feb 2512.64
Jan 2512.66
Jan 2512.82
Jan 2512.83
Jan 2512.57
Jan 2513.07
Dec 2412.89
Dec 2412.85
Dec 2413.26
Dec 2413.66
Nov 2414.19
Nov 2413.94
Nov 2413.77
Nov 2414.81
Nov 2414.12
Oct 2414.77
Oct 2414.67
Price to Book
1.21.41.61.822.2med 1.61Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
SBRA Price to Book by quarter
PeriodPrice to Book
Sep 261.88
Sep 261.9
Aug 261.89
Aug 261.87
Aug 261.86
Aug 261.93
Jul 261.91
Jul 262.02
Jul 261.82
Jul 261.77
Jul 261.82
Jun 261.77
Jun 261.64
Jun 261.69
Jun 261.67
May 261.8
May 261.87
May 261.87
May 261.88
May 261.84
Apr 261.77
Apr 261.83
Apr 261.81
Apr 261.75
Mar 261.73
Mar 261.73
Mar 261.82
Mar 261.8
Feb 261.81
Feb 261.76
Feb 261.78
Feb 261.61
Jan 261.59
Jan 261.6
Jan 261.63
Jan 261.64
Jan 261.63
Dec 251.59
Dec 251.59
Dec 251.63
Dec 251.64
Nov 251.66
Nov 251.59
Nov 251.58
Nov 251.6
Oct 251.56
Oct 251.59
Oct 251.59
Oct 251.56
Oct 251.59
Sep 251.65
Sep 251.64
Sep 251.67
Sep 251.67
Aug 251.68
Aug 251.72
Aug 251.62
Aug 251.64
Aug 251.61
Jul 251.6
Jul 251.59
Jul 251.63
Jul 251.64
Jun 251.61
Jun 251.61
Jun 251.6
Jun 251.57
May 251.54
May 251.54
May 251.57
May 251.6
May 251.5
Apr 251.5
Apr 251.57
Apr 251.5
Apr 251.49
Mar 251.51
Mar 251.49
Mar 251.49
Mar 251.46
Feb 251.43
Feb 251.37
Feb 251.41
Feb 251.42
Jan 251.43
Jan 251.44
Jan 251.45
Jan 251.42
Jan 251.47
Dec 241.45
Dec 241.45
Dec 241.49
Dec 241.54
Nov 241.6
Nov 241.57
Nov 241.55
Nov 241.67
Nov 241.59
Oct 241.58
Oct 241.57
Sabra Health Care REIT, Inc.
SBRA
Stockpicker

Video analysis: SBRA

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: SBRA

3 More Buys In Senior Housing REITs

seekingalpha.com · 10 Sep 2026

3 More Buys In Senior Housing REITs

Senior Housing REITs are outperforming major indices, driven by a persistent supply-demand imbalance and favorable demographic trends. This article previews 3 Senior Housing REITs that offer high yields and strong balance sheets while trading at attractive FFO multiples. All three REITs present robust internal and external growth potential as occupancy rates climb, with yields well above Treasury rates.

Sabra Health Care REIT, Inc., Issues Business Update and will Participate in the BofA Securities 2026 Global Real Estate Conference

businesswire.com · 9 Sep 2026

Sabra Health Care REIT, Inc., Issues Business Update and will Participate in the BofA Securities 2026 Global Real Estate Conference

TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #SBRA--In conjunction with upcoming investor meetings, Sabra Health Care REIT, Inc. (Nasdaq: SBRA) has issued a business update, which is available on the company's website.In addition, Rick Matros, the company's Chair and Chief Executive Officer, Michael Costa, the company's Chief Financial Officer, Darrin Smith, the company's Chief Investment Officer, and Lukas Hartwich, the company's Executive Vice President of Finance, will participate in the BofA Securities 2026 Gl.

Amundi Increases Stock Holdings in Sabra Healthcare REIT, Inc. $SBRA

defenseworld.net · 7 Aug 2026

Amundi Increases Stock Holdings in Sabra Healthcare REIT, Inc. $SBRA

Amundi increased its stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ: SBRA) by 22.7% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 182,620 shares of the real estate investment trust's stock after buying an additional 33,787 shares during

Here Are Thursday’s Top Wall Street Analyst Research Calls: AppLovin, Charles River, Global Payments, HubSpot, Insulet Corporation, Roper Technologies, Sabra Health Care, Western Digital, Zillow Group, and More

247wallst.com · 6 Aug 2026

Here Are Thursday’s Top Wall Street Analyst Research Calls: AppLovin, Charles River, Global Payments, HubSpot, Insulet Corporation, Roper Technologies, Sabra Health Care, Western Digital, Zillow Group, and More

Wall Street analysts made some dramatic moves on Thursday, slashing price targets by double digits on several high-profile names while upgrading others to buy. Find out which stocks got the most surprising treatment before the opening bell.

Sabra Health Care REIT, Inc. (SBRA) Q2 2026 Earnings Call Transcript

seekingalpha.com · 4 Aug 2026

Sabra Health Care REIT, Inc. (SBRA) Q2 2026 Earnings Call Transcript

Sabra Health Care REIT, Inc. (SBRA) Q2 2026 Earnings Call Transcript

Sabra Healthcare REIT Q2 Earnings Call Highlights

marketbeat.com · 4 Aug 2026

Sabra Healthcare REIT Q2 Earnings Call Highlights

Sabra Healthcare REIT NASDAQ: SBRA reported second-quarter 2026 normalized funds from operations of $0.38 per share and normalized adjusted funds from operations of $0.40 per share, with management reaffirming the higher full-year earnings outlook it issued in a July business update.

Sabra Healthcare (SBRA) Tops Q2 FFO and Revenue Estimates

zacks.com · 3 Aug 2026

Sabra Healthcare (SBRA) Tops Q2 FFO and Revenue Estimates

Sabra Healthcare (SBRA) came out with quarterly funds from operations (FFO) of $0.4 per share, beating the Zacks Consensus Estimate of $0.39 per share. This compares to FFO of $0.38 per share a year ago.

Sabra Reports Second Quarter 2026 Results; Reiterates 2026 Guidance

businesswire.com · 3 Aug 2026

Sabra Reports Second Quarter 2026 Results; Reiterates 2026 Guidance

TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #2Q26--Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the second quarter of 2026. SECOND QUARTER 2026 RESULTS AND RECENT EVENTS Results per diluted common share for the second quarter of 2026 were as follows: Net Loss: $(0.10) FFO: $(0.02) Normalized FFO: $0.38 AFFO: $0.39 Normalized AFFO: $0.40 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.49x Senior Housing - Leased: 1.52x B.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.